Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 246.60
+3.00 (1.23%)
Aug 15, 2025, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 52.53 billion as of August 15, 2025. Its market cap has decreased by -7.13% in one year.
Market Cap
52.53B
Enterprise Value
67.65B
Revenue
22.59B
Ranking
n/a
PE Ratio
19.72
Stock Price
246.60
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 52.53B, an increase of 2,379.03%. That is a compound annual growth rate of 11.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 52.53B | -8.67% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | 57.66B | 12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,441.89B |
| Coloplast | 134.87B |
| Genmab | 89.71B |
| ALK-Abelló | 40.63B |
| H. Lundbeck | 37.34B |
| Zealand Pharma | 26.07B |
| Ambu A/S | 24.16B |
| Bavarian Nordic | 18.56B |